Speaker List

We are pleased to announce our 2017 World Preclinical Congress Distinguished Faculty:

 

Adi Diab, M.D., Assistant Professor, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center

Adrian J. Fretland, Ph.D., Associate Director, DMPK Oncology iScience, AstraZeneca

Alejandro Villagra, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University

Alison Harrill, Ph.D., Geneticist, National Toxicology Program Division, National Institute for Environmental Health Sciences

Amitabh Sharma, Ph.D., Assistant Professor, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School

Andrea T. Hooper, Ph.D., Senior Principal Scientist, Pfizer Oncology

Andrew Flick, Ph.D., Senior Principal Scientist, Global R&D, Pfizer, Inc.

Andrew J. Phillips, Ph.D., President and CSO, C4 Therapeutics

Andrew Ravanelli, Ph.D., Senior Research & Development Scientist, Genome & Epigenome Editing, MilliporeSigma

Andrew Wang, M.D., Associate Professor, Director of Clinical and Translational Research, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill

Andy Zhu, Ph.D., Senior Manager, Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International

Angie Inkyung Park, Ph.D., Senior Director, Immunotherapy and Stem Cells, OncoMed Pharmaceuticals

Anil K. Sood, M.D., Professor, Department of Gynecologic Oncology and Department of Cancer Biology, MD Anderson Cancer Center

Anil Vasudevan, Ph.D., Director, Discovery Chemistry and Technology (DCAT), AbbVie

Anka G. Ehrhardt, Ph.D., Director, Clinical Cytometry, Translational Medicine, BMS

Annette Gilchrist, Ph.D., Professor, Pharmacology, Midwestern University

Annick D. Van Den Abbeele, M.D., Associate Professor, Radiology, Harvard Medical School; Chief, Department of Imaging, Dana-Farber Cancer Institute; Founding Director, Center for Biomedical Imaging in Oncology (CBIO), Imaging, Dana-Farber Cancer Institute

Antti Nurmi, Ph.D., Director, Science, Discovery, Charles River

Apostolos Pappas, Ph.D., Research Manager and Fellow, Emerging Science and Innovation, Johnson & Johnson Consumer, Inc.

Ariamala Gopalsamy, Ph.D., Associate Research Fellow, Medicine Design, Pfizer, Inc.

Axel H. Meyer, Ph.D., Head of Brain Delivery, Neuroscience Discovery, AbbVie GmbH & Co. KG

Ayman El-Kattan, Ph.D., Associate Research Fellow, Pdm, Pfizer

Azusa Tanaka, Ph.D., Product Manager, Precision Research Model, Taconic Biosciences

Balu Chakravarthy, Ph.D., Senior Research Officer, National Research Council Canada

Benjamin G. Cuiffo, Ph.D., Scientist, Biomodels, LLC

Bernard Faller, Director, Discovery ADME, Novartis Institutes for BioMedical Research, Basel

Bernard Faller, Ph.D., Director Discovery ADME, Novartis Institutes for BioMedical Research, Basel, Switzerland

Birgitt Schuele, M.D., Director for Gene Discovery and Stem Cell Modeling, Translational Sciences, Parkinson's Institute and Clinical Center

Brandon Lamarche, Ph.D., Research Scientist, ACEA Biosciences

Brian B. Haines, Ph.D., Principal Scientist, Pharmacology, Merck

Brian Czerniecki, M.D., Ph.D., Chair and Senior Member, Department of Breast Oncology, Moffitt Cancer Center

Brian Lamon, Ph.D., Head, II-ON & Lead, Oncology Academic Research, BMS

Carol Moraff, Scientific Associate I, Novartis Institutes for BioMedical Research

Celia Dominguez, Ph.D., Vice President, Chemistry, CHDI Management/CHDI Foundation Inc.

Ceren Korkut, Ph.D., Scientist, Chemical Biology, Biogen

Changning Wang, Ph. D., Instructor, Martinos Center, Massachusetts General Hospital

Cheng Song, Ph.D., Scientific Leader, Developmental Molecular Pathway, Novartis Institutes for BioMedical Research

Chengzu Long, Ph.D., Assistant Professor, Division of Cardiology, New York University School of Medicine

Chi-Ping Day, Ph.D., Staff Scientist, Cancer Modeling Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health

Christian Schmees, Ph.D., Head of Tumor Biology, Molecular Biology Department, NMI Natural and Medical Sciences Institute at the University of Tübingen

Christiane Chbib, Pharm.D, Ph.D., Assistant Professor, Pharmaceutical Sciences, Larkin College of Pharmacy

Christoph Patsch, Ph.D., Principle Scientist, Team Lead, Stem Cell Assays, Roche Innovation Center

Christopher Heery, M.D., CMO, Bavarian Nordic

Christopher Lock, B.Sc., Ph.D., Senior Scientist, Discovery, Charles River

Christopher Schulze, Ph.D., Postdoctoral Research Fellow, Pathology (Bogyo Lab), Stanford University School of Medicine

Chunxiao Xu, Ph.D., Principal Scientist, Immuno-Pharmacology and Immuno-Oncology, EMD Serono

Claudia McGinnis, Ph.D., Principal Scientist & Group Leader, Pharma Research and Early Development, Pharmaceutical Sciences, Mechanistic Safety, Roche Innovation Center Basel

Clifford Steer, M.D., Professor of Medicine and Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School

Craig Ferris, Ph.D., Professor, Psychology and Pharmaceutical Sciences, Director, Center for Translational NeuroImaging, Northeastern University

Cristianne J.F. Rijcken, Pharm.D., Ph.D., Founder and CSO, Cristal Therapeutics

Cynthia Guidos, Ph.D., Senior Scientist, Program in Developmental & Stem Cell Biology, Hospital for Sick Children Research Institute, Peter Gilgan Centre for Research and Learning

Dag Sehlin, Ph.D., Researcher, Department of Public Health/Geriatrics, Uppsala University, Ph.D., Assistant Professor, Radiology, Johns Hopkins University

Danica Stanimirovic, M.D., Ph.D., Director, Translational Bioscience Department, Human Health Therapeutics Portfolio, National Research Council of Canada

Daniel G. Anderson, Ph.D., Associate Professor, Department of Chemical Engineering, Institute for Medical Engineering and Science, Harvard-MIT Division of Health Sciences & Technology, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Daniel Kagan, Ph.D., COO, Scientist

Daniela Cipolletta, Ph.D., Lab Head, Investigator III, Immuno-Oncology, Novartis Institutes for BioMedical Research

Danielle Graham, Ph.D., Director, Neurodegenerative Disease, Biomarker Discovery and Development, Biogen

Danilo A. Tagle, Ph.D., MS, Associate Director, Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences (NCATS), NIH

Danilo Maddalo, Ph.D., Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research, Novartis Pharma AG

Dario Vignali, Ph.D., Vice Chair and Professor of Immunology, University of Pittsburgh School of Medicine

David Bumcrot, Ph.D., Senior Director, Molecular & Cell Biology, Editas Medicine

David Tuck, M.D., CMO, Curis, Inc.

Dean C. Bottino, Ph.D., Scientific Director, Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International

Denise Faustman, M.D., Ph.D., Director, Immunobiology & Associate Professor, Medicine, Immunobiology, Massachusetts General Hospital, Harvard Medical School

Denise Karaoglu Hanzatian, Ph.D., Principal Research Scientist, Biologics Discovery, AbbVie Bioresearch Center, AbbVie

Donald E. Ingber, M.D., Ph.D., Founding Director, Wyss Institute for Biologically Inspired Engineering, Harvard University; Judah Folkman Professor of Vascular Biology, Harvard Medical School & Boston Children's Hospital; and Professor of Bioengineering, John A. Paulson School of Engineering & Applied Sciences, Harvard University

Dong Chen, Ph.D., Professor, Institute of Process Equipment, College of Energy Engineering, Zhejiang University

Douglas Wilson, Ph.D., Associate Principal Scientist, Merck

Elaine Hurt, Ph.D., Senior Scientist, MedImmune

Elizabeth Evans, Ph.D., Vice President, Preclinical Research, Vaccinex

Eric Kmiec, Ph.D., Director, Gene Editing Program and Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System

Eric Yvon, Ph.D., Director, CAR Program, Research and Development, Bellicum Pharmaceuticals, Inc.

Fabrizio Piazza, Ph.D., Principal Investigator, iCAβ International Network Coordinator, School of Medicine, University of Milano-Bicocca

Frank S. Walsh, Ph.D., CEO, Ossianix

G. Ian Gallicano, Ph.D., Associate Professor, Department of Biochemistry and Molecular & Cellular Biology, and Director, Transgenic Core Facility, Georgetown University Medical Center

Gary C. Starling, Ph.D., Associate Vice President, MRL Biologics and Vaccines Discovery, Merck

Gary Gintant, Ph.D., Senior Research Fellow, Integrative Pharmacology, Integrated Science and Technology, AbbVie

Geoffrey Bartholomeusz, Ph.D., Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center

George M. Burslem, Ph.D., Research Associate, Molecular, Cellular and Developmental Biology, Yale University

Gerd Wagner, Ph.D., Reader in Medicinal Chemistry, Department of Chemistry, King's College London

Graham Smith, Ph.D., Director, Director Medicinal Chemistry, New Modalities, Medicinal Chemistry, Merck Research Laboratories

Hannes Hahne, Ph.D., CEO, OmicScouts GmbH

Hao Yin, Ph.D., Research Scientist, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Harvey Cantor, M.D., Baruj Benacerraf Professor, Microbiology & Immunobiology; Chairman, Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute

Henning Stockmann, Ph.D., Senior Scientist, Chemical Biology, Global Pharmaceutical Research and Development, AbbVie Inc.

Hiruy Meharena, Ph.D., Postdoctoral Fellow, Tsai Lab, Massachusetts Institute of Technology (MIT)

Hua Xu, Ph.D., Principal Scientist, Medicine Design, Pfizer

Ian McNiece, Ph.D., Executive Consultant, CellMed Consulting

Ian Sweet, Ph.D., Associate Professor, Department of Medicine, University of Washington

James E. Talmadge, Ph.D., Professor Department of Pathology and Microbiology, Director Laboratory of Transplantation Immunology, Editor-in-Chief International Immunopharmacology, Transplantation Immunopharmacology, University of Nebraska Medical Center

James J. Hickman, Ph.D., Professor, Nanoscience Technology, Chemistry, Biomolecular Science, and Electrical Engineering, University of Central Florida

James Kasuboski, Ph.D., Postdoctoral Fellow, Neuroscience, Pfizer

James Smothers, Ph.D., Senior Director & Head, Discovery, Immuno-Oncology & Combinations DPU, GlaxoSmithKline

Jarrod Marto, Ph.D., Associate Professor, Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute

Jayaprakasam Bolleddula, Ph.D., Senior Scientist II (Associate Director), Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals

Jean-Francois Mirjolet, Ph.D., Technology Director, Oncodesign

Jeffrey Borenstein, Ph.D., Laboratory Technical Staff, Biomedical Microsystems, Draper

Jeffrey Hanke, Ph.D., CSO, Tesaro

Jeffrey Johannes, Ph.D., Associate Principal Scientist, IMED Oncology Medicinal Chemistry, AstraZeneca

Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines

Jennifer Listgarten, Ph.D., Senior Researcher, Microsoft Research

Jennifer Smith, Ph.D., Assistant Director, ICCB-Longwood Screening Facility, Harvard Medical School

Jijie Gu, Ph.D., Research Fellow, Immunology and Global Biologics, AbbVie Bioresearch Center

Johan Luthman, Ph.D., Vice President, Neuroscience Clinical Development, Neurology Business Group, Eisai, Inc

Johan Ulrik Lind, Ph.D., Research Associate, Disease Biophysics Group, John A. Paulson School of Engineering and Applied Sciences, Wyss Institute for Biologically Inspired Engineering, Harvard University

John Doench, Ph.D., Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT

John Erve, Ph.D., Consultant

John G. Quinn, Ph.D., Head of Molecular Biophysics & Senior Scientist, Biochemistry & Cellular Pharmacology, Genentech a member of the Roche Group

John P. Wikswo, Ph.D., Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Vanderbilt University

John Santa Maria, Ph.D., Research Fellow, Cheminformatics, Merck

Jonathan Garlick, D.D.S., Ph.D., Professor, School of Dental Medicine, Tufts University; Director, Division of Cancer Biology and Tissue Engineering, Tufts School of Medicine, School of Engineering and Sackler School of Graduate Biomedical Sciences

Jonathan Levenson, Ph.D., Senior Director, Preclinical Research and Development, Proclara Biosciences

Jonathan Zalevsky, Ph.D., Vice President, Biology & Preclinical Development, Nektar Therapeutics

Jose A. Lebron, Ph.D., Executive Director, Investigative Laboratory Sciences, Safety Assessment & Laboratory Animal Resources, Merck & Co., Inc.

Joseph Charest, Ph.D., Program Manager, Biomedical Solutions, Draper

Jürgen Moll, Ph.D., Director, Pharmacology and Translational Research, Boehringer Ingelheim

Kambez H. Benam, D.Phil., Technology Development Fellow, Wyss Institute for Biologically Inspired Engineering, Harvard University

Kap-Sun Yeung, Ph.D., Principal Scientist, Discovery Chemistry, Bristol-Myers Squibb

Karuppiah Kannan, Ph.D., Associate Director, Cancer Pharmacology, Takeda Pharmaceuticals International

Katherine Bakshian Chiappinelli, Ph.D., Assistant Professor, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University Cancer Center

Kent Werner, M.D., Ph.D., Co-Founder and CEO, Cogentis Therapeutics; Johns Hopkins Neurology Adjunct Faculty

Kevin C. Eggan, Ph.D., Harvard Department of Stem Cell and Regenerative Biology, Director of Stem Cell Biology, Stanley Center for Psychiatric Research at the Broad Institute

Kevin C. Eggan, Ph.D., Harvard Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute

Kevin Lumb, Ph.D., Global Head of Screening, Discovery Sciences, The Janssen Pharmaceutical Companies of Johnson & Johnson

Kieran F. Geoghegan, Ph.D., Research Fellow, Pfizer Worldwide Research

Kimberly Homan, Ph.D., Research Associate, Lewis Research Group, Wyss Institute for Biologically Inspired Engineering, Harvard University

Klara Valko, Ph.D., Director/Honorary professor, Bio-Mimetic Chromatography

Kohei Shigeta, M.D., Ph.D., Research Fellow, Duda Lab, Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School

Kurt A. Schalper, M.D., Ph.D., Assistant Professor of Pathology and Medicine (Medical Oncology), Yale School of Medicine, Director, Translational Immuno-Oncology Laboratory, Yale Cancer Center

Larry Park, Ph.D., Director, In Vivo Research, CHDI

Laszlo Urban, M.D., Ph.D., Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for BioMedical Research, Inc.

Lawrence Tamarkin, Ph.D., President & CEO, CytImmune

Lee Rubin, Ph.D., Professor, Stem Cell & Regenerative Medicine, Harvard University; Director, Translational Medicine, HSCI

Leigh Zawel, Vice President and Site Head, New York and Boston Centers for Therapeutic Innovation, Pfizer

Leonard Khiroug, Ph.D., CSO, Neurotar Ltd

Lieven Meerpoel, Ph.D., Senior Director, Janssen Lead Discovery, Janssen R&D

Lijun Sun, Ph.D., Director, Center for Drug Discovery and Translational Research, Beth Israel Deaconess Medical Center, Harvard Medical School

Lois A. Lampson, Ph.D., Associate Professor of Neurosurgery, Brigham & Women's Hospital/Harvard Medical School

Lorenzo Galluzzi, Ph.D., Assistant Professor of Cell Biology Research, Radiation Oncology, Weill Cornell, Weill Cornell Medical College

Lorin Jakubek, Ph.D., Scientist III, In Vitro Biology, Sanofi Genzyme

Luise U. Weigand, Ph.D., Team Leader, Cell Biology, Immunocore Ltd.

Lyn Jones, Ph.D., Head of Rare Diseases Chemistry, Chemical Biology Group Leader, Pfizer Inc.

M. Paola Castaldi, Ph.D., Head, Chemical Biology Team, Discovery Sciences, R&D Boston, AstraZeneca

Madhu Lal-Nag, Ph.D., Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Malte Tiburcy, M.D., Research Fellow, Institute of Pharmacology and Toxicology, University Medical Center Goettingen

Manfred Kraus, Ph.D., Director, In vivo Pharmacology, Tumor Cell Biology, Pfizer Oncology

Manu Sebastian, Ph.D., Associate Professor and Director, Research Histology, Pathology & Imaging Core, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center

Manuel Sanchez-Felix, Senior Fellow, Chemical & Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, Cambridge

Manuela Polydoro, Ph.D., Investigator II, Neuroscience, Novartis Institutes for BioMedical Research, Inc.

Marcus Bosenberg, M.D., Ph.D., Associate Professor of Dermatology and Pathology, Yale University, Co-Leader, Genomics, Genetics and Epigenetics Program, Yale Cancer Center

Mario Perro, Ph.D., Group Leader, Pharmacology, Oncology, Roche

Mark Smythe, Ph.D., Founder & VP, Protagonist Therapeutics

Markus Schirle, Ph.D., Senior Investigator, Developmental and Molecular Pathways/ Chemogenetics, Novartis Institutes for BioMedical Research

Martin Pettersson, Ph.D., Associate Research Fellow, Neuroscience & Pain Medicinal Chemistry, Pfizer Inc.

Mary Ellen Cvijic, Ph.D., Director, Lead Evaluation & Lead Profiling, Department of Lead Discovery and Optimization, Bristol-Myers Squibb

Mary Woodall-Jappe, Ph.D., Director, US Discovery Biology-Oncology, Eisai

Matt Gevaert, Ph.D., CEO and Co-Founder, KIYATEC

Matt Lucas, Ph.D., Director, Medicinal Chemistry, Yumanity Therapeutics

Matthew Robers, Senior Research Scientist, Research & Development, Promega Corporation

Mazhar Adli, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine

Michael A. Curran, Ph.D., Assistant Professor, Immunology, The University of Texas MD Anderson Cancer Center

Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University

Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School

Michael Burnet, Ph.D., Managing Director, Oncology Discovery, Synovo GmbH

Michael K. Ahlijanian, Ph.D., Director, Discovery Biology and Head, Clinical Biomarkers, Bristol-Myers Squibb

Michael Michaelides, Ph.D., Head, Oncology Chemistry, Senior Research Fellow, AbbVie

Michael P. Clark, Director, Department of Chemistry, Vertex Pharmaceuticals Inc.

Michael Rosenzweig, D.V.M., Ph.D., Executive Director, Oncology-Discovery, Merck Research Laboratories

Michel Bouvier, Ph.D., Professor/General Director, Biochemistry and Molecular Medicine/Institute for Research in Immunology and Cancer, Université de Montréal

Mingxiang Liao, Ph.D., Senior Scientist I, DMPK, Takeda Pharmaceutical Intl. Company

Mohammad F. Kiani, Ph.D., FAHA, Professor, Mechanical Engineering, Bioengineering, and Radiation Oncology, Temple University

Murali Gopalakrishnan, Ph.D., Senior Director, Head Search & Evaluation Neuroscience, AbbVie

Nadine Tatton, Ph.D., Scientific Director, The Association for Frontotemporal Degeneration

Natalie Artzi, Ph.D., Assistant Professor, Medicine, Brigham and Women's Hospital

Nazish Sayed, M.D., Ph.D., Instructor, Cardiovascular Institute, Stanford University School of Medicine

Nello Mainolfi, Ph.D., Senior Director, Head of Drug Discovery, Raze Therapeutics

Neville Sanjana, Ph.D., Core Faculty Member, New York Genome Center and Assistant Professor, Department of Biology & Center for Genomics and Systems

Nicolo Fusi, Ph.D., Researcher, Microsoft Research

Norbert Perrimon, Ph.D., Professor, Department of Genetics, Harvard Medical School

Noushin Dianat, Ph.D., Bioengineering Team Leader, Colloids & Divided Materials Lab, ESPCI Paris

Osama Rahma, M.D., Member of the Faculty of Medicine, Center for Immune-Oncology, Dana-Farber Cancer Institute

Pablo Perez-Pinera, M.D., Ph.D., Assistant Professor, Department of Bioengineering, University of Illinois at Urbana-Champaign

Patricia Ganey, Ph.D., Professor, Department of Pharmacology and Toxicology, Institute for Integrative Toxicology, Michigan State University

Patrick Sweeney, Ph.D., Managing Director, DRS Finland, Charles River Laboratorie

Paul B. Watkins, M.D., Director, Institute for Drug Safety Sciences, Howard Q. Ferguson Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Paul Diehl, Ph.D., COO, Cellecta, Inc.

Paul Enríquez, J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry, North Carolina State University

Paul Trippier, Ph.D., Assistant Professor, Pharmaceutical Sciences, Texas Tech University Health Sciences Center

Paula Miliani de Marval, Ph.D., Senior Research Scientist, Charles River

Per-Ola Freskgard, Ph.D., Vice Director and Senior Leader, Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Peter Cook, Ph.D., Postdoctoral Researcher, Laboratory of Andrea Ventura, M.D., Ph.D., Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center

Peter Hammerman M.D., Ph.D., Global Head, Translational Research, Oncology, Novartis

Peter Kutchukian, Ph.D., Associate Principal Scientist, Cheminformatics, Merck

Piyush Bajaj, Ph.D., Senior Scientist, Drug Safety R&D, Investigative Toxicology Group, Pfizer

Pottayil G. Sasikumar, Ph.D., Associate Research Director, Medicinal Chemistry, Aurigene Discovery Technologies Ltd.

Pradip Majumder, Ph.D., CSO, Mitra Biotech

Puja Sapra, Executive Director, Oncology Research and Development, Pfizer

Qin Wang, Ph.D., Principal Scientist, Translational Sciences, Biogen

Quang-Dé Nguyen, Ph.D., Director, Lurie Family Imaging Center, Senior Scientist, Center for Biomedical Imaging in Oncology, Research Associate in Radiology, Harvard Medical School

R. James Christie, Scientist, Antibody Discovery and Protein Engineering, MedImmune Research

Rhiannon Hardwick, Ph.D., Scientist II, Tissue Applications, Organovo

Ricardo Dolmetsch, Ph.D., Global Head, Neuroscience, Novartis Institutes for Biomedical Research

Robert D. Bell, Ph.D., Senior Principal Scientist, Neurovascular Biology Lab Head, Pfizer, Inc.

Robert Pearlstein, Ph.D., Senior Research Investigator I, Novartis Institutes for BioMedical Research

Roberta Zappasodi, Ph.D., Research Scholar, The Jedd Wolchok Lab, Memorial Sloan Kettering Cancer Center

Robin Kleiman, Ph.D., Director, Preclinical Research, Translational Neuroscience Center, Boston Children's Hospital

Robyn S. Klein, M.D., Ph.D., Director, Center for Neuroimmunology & Neuroinfectious Diseases, Department of Internal Medicine, Neurobiology, Pathology & Immunology, Washington University School of Medicine

Roderick Beijersbergen, Ph.D., Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center

Ronald Alfa, Ph.D., Director, Translational Biology, Recursion Pharmaceuticals

Ru Gunawardane, Ph.D., Director, Stem Cells and Gene Editing, Allen Institute for Cell Science

Ruben Boado, Ph.D., Vice President, Research & Development/Co-Founder, ArmaGen, Inc.

Salvador Ventura, Ph.D., Professor/Group Leader, Department of Biochemistry and Molecular Biology, Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona

Sangeetha Palakurthi, Ph.D., Head of Cancer Biology and Pharmacology, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute

Sanjay Prakadan, Ph.D., The Shalek Lab, MIT Institute for Medical Engineering & Science

Sarah Javaid, Ph.D., Senior Scientist, Discovery Pharmacogenomics, Genetics, Pharmacogenomics, Merck

Sarah McWhirter, Ph.D., Director, STING Program, Aduro Biotech

Scott Collins, Ph.D., Scientist, Novartis Institutes for BioMedical Research Inc

Scott Lokey, Ph.D., Professor, PBSci-Chemistry & Biochemistry Department, Physical & Biological Sciences, University of California Santa Cruz

Sean P. Brown, Ph.D., Principal Scientist, Medicinal Chemistry, Amgen

Serena Silver, Ph.D., Senior Investigator, Group Leader, Molecular Pharmacology, Novartis Institutes for BioMedical Research

Seyoum Ayehunie, Ph.D., Vice President, MatTek Corporation

Shane Olwill, Ph.D., Vice President, Head of Development & Immuno-Oncology, Pieris Pharmaceuticals

Sharin Roth, Ph.D., Director, Clinical Pharmacology, Bioanalytical & Biomarkers, Otsuka Pharmaceuticals

Shawn Je, Ph.D., Assistant Professor, Program in Neuroscience and Behavioral Disorders, Duke-National University of Singapore Medical School

Shawna Jackman, Ph.D., DABT, Principal Research Scientist, Photobiology, Charles River Laboratories

Shruthi Agrawal, Ph.D., Director, Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb Co.

Sid Topiol, Ph.D., CSO, 3D-2drug, LLC; Professor and Director, Structural and Computational Drug Discovery, Stevens Institute of Technology

Simrit Parmar, M.D., Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Soner Altiok, MD, Ph.D., CSO, Nilogen Oncosystems

Stefano Crosignani, Ph.D., Director, Medicinal Chemistry, iTeos Therapeutics

Stephen J. Shuttleworth, Ph.D., FRSC CChem, CSO, Karus Therapeutics Ltd.

Suresh Kumar, Ph.D., Director, R&D, Progenra, Inc.

Suzanne Skolnik, Investigator, Analytical Chemistry Group, Novartis Institutes for BioMedical Research, Cambridge

Svetlana Hamm, Ph.D., Head, Translational Pharmacology, 4SC Group

Svetlana Sadekova, Ph.D., Senior Principal Scientist, Head of Translational Pathology Group, Merck

Terry Kenakin, Ph.D., Professor, Department of Pharmacology, University of North Carolina School of Medicine

Terry Van Vleet, Ph.D., DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie

Theresa D'Souza, Ph.D., Section Manager, Cell Biology Research & Technology, Lonza Walkersville, Inc.

Thomas J. Goodwin, Ph.D., NASA (retired) & Sovaris Aerospace

Thomas Oliver Kleen, Ph.D., Executive Vice President, Immune Monitoring, Epiontis GmbH

Tim Robertson, Ph.D., CEO, Vium

Torben Moos, Ph.D., The Faculty of Medicine, Department of Health Science and Technology, Laboratory of Neurobiology, Aalborg University

Tracy L. Young-Pearse, Ph.D., Assistant Professor, Neurology, Brigham and Women's Hospital and Harvard Medical School

Travis Beckett, M.S., Scientist, Flow Cytometry Team Lead, Technology Research & Development, Juno Therapeutics

Tricia A. Thornton-Wells, Ph.D., Investigator III / Clinical Genetics Expert, Neuroscience Disease Area Portfolio Leader, Novartis Institutes for BioMedical

Tricia May-Dracka, Ph.D., Scientist II, Chemistry and Molecular Therapeutics, Biogen

Ulrich Broeckel, M.D., Professor of Pediatrics, Medicine and Physiology, Pediatrics, Medical College of Wisconsin

Vasileios Askoxylakis, M.D., Ph.D., Medical Director, Merrimack Pharmaceuticals

Walter C. Low, Ph.D., Professor and Associate Head for Research, Department of Neurosurgery, Stem Cell Institute, University of Minnesota Medical School

Weiming Xia, Ph.D., Acting Associate Director of Research, Geriatric Research Education Clinical Center, Bedford VA Hospital

Will Proctor, Ph.D., Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech

William Proctor, Ph.D., DABT, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech, Inc

William Z. Potter, M.D., Ph.D., Senior Advisor, National Institute of Mental Health

Xingxing Zang, Ph.D., Associate Professor, Microbiology and Immunology & Medicine, Albert Einstein College of Medicine

Xuan Zhang, M.D., Ph.D., Division of NeuroToxicology, National Center for Toxicological Research, FDA

Yejing Ge, Ph.D., Postdoctoral Fellow, Laboratory of Dr. Elaine Fuchs, Department of Mammalian Cell Biology and Development, Rockefeller University

Ying-Chou Chen, Ph.D., Postdoctoral Associate, Laboratory of Dr. Timothy Lu, Synthetic Biology Center, Massachusetts Institute of Technology

Yoojin Shin, Ph.D., Postdoctoral Fellow, Mechanical Engineering, MIT

Yuan Wang, Ph.D., Investigator III, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research

Yung-Chih Cheng, Ph.D., Postdoctoral Research Fellow, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Department of Neurobiology, Harvard Medical School

Yuyu Niu, Ph. D., Associate Director, Yunnan Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, China

Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute of Biomedical Research

Zhenfeng Duan, M.D., Ph.D., Assistant Professor, Orthopedic Surgery, Harvard Medical School and Massachusetts General Hospital

Zohreh Amoozgar, Pharm.D., Ph.D., Postdoctoral Research Fellow, Radiation Oncology, MGH, Harvard Medical School

Yung-Chih Cheng, Ph.D., Postdoctoral Research Fellow, F.M. Kirby Neurobiology

Yuyu Niu, Ph. D., Associate Director, Yunnan Key Laboratory of Primate Biomedical

Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute

Zhenfeng Duan, M.D., Ph.D., Assistant Professor, Orthopedic Surgery, Harvard

Zohreh Amoozgar, Pharm.D., Ph.D., Postdoctoral Research Fellow, Radiation

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Premier Sponsor

 Charles River Discovery

Mitra Biotech

Scientist

Arrow Short Courses

Arrow Sponsors

Arrow Media Partners

Arrow Symposia

Arrow Posters



Download Brochure(PDF)
Industry Event Calendar
Search for Pharmaceuticals